Lipid profile peroxidation among Ghanaian pregnancy-induced hypertensives

Journal of Medical Sciences

Volumn 8, Issue 8, 2008, Pages 691-698

  Ahenkorah, L ^a   Owiredu, W K B A ^a   Laing, E F ^a   Amidu, N ^a   Turpin, C A ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Anmthropometric data; Induced hypertension; Malondialdehyde; Normotensive pregnant women; Oxidative stress; Pregnancy

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OXIDATIVE STRESS; PREECLAMPSIA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 67649556102     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2008.691.698     Document Type: Article

References (46)

1. Adegoke, O.A., E.E. Iyare and S.Q. Gbenebitse, 2003. Fasting plasma glucose and cholesterol levels in pregnant Nigerian women. Niger. Postgraduate Med. J., 10: 32-36.
2. Bartham, D. and P. Trinder, 1972. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst, 97:142-145.
3. Bellany, L., J.P. Casas, A.D. Hingorani and D.J. Williams, 2007. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and Meta-analysis. Br. Med. J., 335: 974-974.
4. Belo, L., M. Caslake, D. Gaffney, A. Santos-Silva, L. Pereira-Leite, A. Quintanilha and I. Rebelo, 2002. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis, 162: 425-432.
5. Cekmen, M.B., A.B. Erbagci, A. Balat C. Duman, H. Maral, K. Ergen, M. Ozden, O. Balat and S. Kuskay, 2003. Plasma lipid and lipoprotein concetrations in pregnancy induced hypertension. Clin. Biochem., 36: 575-578.
6. D'Ischia, M., A. Palumbo and F. Buzzo, 2000. Interactions of nitric oxide with lipid peroxidation products under aerobic conditions: Inhibitory effects on the formation of malondialdehyde and related thiobarbituric acid-reactive substances. Nitric Oxide, 4: 4-14.
7. Erel, C.T., L.M. Senturk, E. Oral, H. Mutlu, U. Colgar, H. Seyisoglu and E. Ertungealp, 1999. Results of the ACTH stimulation test in hirsute women. J. Reprod. Med., 44: 247-252.
8. Forest, J.C., Girouard, J. Masse, J.M. Moutquin, A. Kharfi, R.B. Ness, S.M. Roberts and Y. Giguere, 2005. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet. Gynecol., 105: 1373-1380.
9. Friedman, S.A., R.N. Taylor and J.M. Roberts, 1991. Pathophysiology of preeclampsia. Clin. Perinatol., 18;661-682.
10. Glueck, C.J., R.W. Fallat and D. Scheel, 1975. Effects of estrogenic compounds on triglyceride kinetics. Metabolism, 24: 537-545.
11. Gratacos, E., 2000. Lipid-mediated endothelial dysfunction: A common factor to preeclampsia and chronic vascular disease. Eur. Obstet. Gynecol. Reprod. Biol., 92: 63-66.
12. Gulmezoglu, A.M., G.J. Hofmeyr and M.M. Oosthuisen, 1997. Antioxidants in the treatment of severe preeclampsia: An explanatory randomised controlled trial. Br. J. Obstet. Gynaecol., 104: 689-696.
13. Hubel, C.A., 1999. Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med., 222: 222-235.
14. Hubel, C.A., F. Lyall, L. Weissfeld, R.E. Gandley and J.M. Roberts, 1998. Small low-density lipoproteins. and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism, 47: 1281-1288.
15. Hubel, C.A., J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rogers and M.K. McLaughlin, 1989. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am. J. Obstet. Gynecol., 161: 1025-1034.
16. Jain, S.K. and R. Wise, 1995. Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia. Mol. Cell. Biochem., 151: 33-38.
17. Kaaja, R., M.J. Tikkanen, L. Viinikka and O. Ylikorkala, 1995. Serum lipoproteins, insulin and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet. Gynecol., 85: 353-356.
18. Kamal, A.A., A. Gomaa, M. el Khafif and A.S. Hammad, 1989. Plasma lipid peroxides among workers exposed to silica or asbestos dusts. Environ. Res., 49: 173-180.
19. Kirkendall, W.M., A.C. Burton, F.H. Epstein and E.D. Freis, 1967. Recommendations for human blood pressure determination by sphygmomanometers. Circulation, 36: 980-988.
20. Kokia, E., G. Barkal, B. Reichman, P. Segal, B. Goldman and S. Mashiach, 1990: Maternal serum lipid profile in pregnancies complicated by hypertensive disorders. J. Perinat. Med., 18: 473-478.
21. Krishna Mohan, S. and G. Venkataramana, 2007. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin, E and antioxidant enzymes in patients with pregnancy-induced hypertension. Indian J. Physiol. Pharmacol., 51: 284-288.
22. Ludwig M., M. Morris and C.D., Sladek, 1997. Effects of antisense oligodeoxynucleotides on peptide release from hypothalamoneurohypophysial explants. Am. J. Physiol. Regulat. Integrat. Comparat. Physiol., 41: R1441-R1446.
23. Madazli, R., A. Benian, K. Grumustas, H. Uzun, V. Ocak and F. Aksu, 1999. Lipid peroxidation and antioxidants in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 85: 205-208.
24. Meyer, N.L., B.M. Mercer, S.A. Friedman and B.M. Sibai, 1994. Urinary dipstick protein: A poor predictor of absent or severe proteinuria. Am. J. Obstet. Gynecol., 170: 137-141.
25. Mikhail, M.S., J. Basu, P.R. Palari, J. Furgiuele, S.L. Romney and A. Anyaegbunam, 1995. Lipid profile in women with preeclampsia: Relationship between plasma triglyceride levels and severity of preeclampsia. J. Assoc. Acad. Minor. Phys., 6: 43-45.
26. Mutlu-Turkoglu, U., E. Ademoglu, L. Ibrahimoglu, G. Aykac-Toker and M. Uysal, 1998. Imbalance between lipid peroxidation and antioxidant status in preeclampsia. Gynecol. Obstet. Invest., 46: 37-40.
27. Narin, F., N. Narin, H. Pasaoglu, K. Uzum and R. Erdogan, 2000. Nitric oxide level in children with pulmonary hypertension. Indian J. Physiol. Pharmacol., 44: 335-339.
28. O'Donnell, V.B., P.H. Chumley, N. Hogg, A. Bloodsworth, V.M. Darley-Usmar and B.A. Freeman, 1997. Nitric oxide inhibition of lipid peroxidation: Kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry, 36: 15216-15223.
29. Osei-Nketiah, S., 2001. Maternal mortality at Effia nkwanta Regional Hospital, Ghana-A one year review (January-December, 1998). Ghana Med. J., 35: 124-129.
30. Ozan, H., Y. Ilcol, Y. Kimya, C. Cengiz and B. Ediz, 2002. Plasma anti-oxidant status and lipid profile in non-gravida women with a history of pre-eclampsia. J. Obstet. Gynaecol. Res., 28: 274-279.
31. Paternoster, D.M., A. Stella, M. Mussap, M. Plebani, G. Gambaro and P.V. Grella, 1999. Predictive markers of pre-eclampsia in hypertensive disorders of pregnancy. Int. J. Gynaecol. Obstet., 66: 237-243.
32. Plaa, G.L. and H. Witschi, 1976. Chemicals, drugs and lipid peroxidation. Annu. Rev. Pharmacol. Toxicol., 16: 125-141.
33. Roberts, J.M., 1998. Endothelial dysfunction in preeclampsia. Semin Reprod. Endocrinol., 16: 5-15.
34. Roberts, J.M., R.N. Taylor, T.J. Musci G.M. Rodgers, C.A. Hubel and M.K. McLaughlin, 1989. Preeclampsia: An endothelial cell disorder. Am. J. Obstet. Gynecol., 161: 1200-1204.
35. Sato, M., T. Miyazaki, T. Nagaya, Y. Murata, N. Ida, K. Maeda and H. Seo, 1996. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1 and collagenase expression in cultured human synovial cells. J. Rheumatol., 23: 432-438.
36. Sattar, N., A. Bendomir, C. Berry, J. Shepherd, I.A. Greer and C.J. Packard, 1997. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet. Gynecol., 89: 403-408.
37. Sattar, N., I.A. Greer, J. Louden, G. Lindsay, M. McConnell, J. Shepherd and C.J. Packard, 1997. Lipoprotein subfraction changes in normal pregnancy: Threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J. Clin. Endocrinol. Metab., 82: 2483-2491.
38. Schonfeld, G., 1979. Lipoproteins in atherogenesis. Artery, 5: 305-329.
39. Seely, E.W. and C.G. Solomon, 2003. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab., 88: 2393-2398.
40. Shlafer, M. and B.M. Shepard, 1984. A method to reduce interference by sucrose in the detection of thiobarbittric acid-reactive substances. Anal. Biochem., 137: 269-276.
41. Sies, H., 1991. Oxidative stress: From basic research to clinical application. Am. J. Med., 91: 31S-38S.
42. Solomon, C.G. and E.W. Seely, 2001. Brief review: Hypertension in pregnancy: A manifestation of the insulin resistance syndrome? Hypertension, 37: 232-239.
43. Trinder, P., 1969. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol., 22: 158-161.
44. Turpin, C.A., L. Ahenkorab, W.K.B.A. Owiredu, E.F. Laing and N. Amidu, 2008. The prevalence of the metabolic syndrome among Ghanaian Pregnancy-Induced Hypertensive patients using the World Health Organisation and the National Cholesterol Education program III criteria. J. Med. Sci., 8: 443-451.
45. Vane, J.R. and R.M. Botting, 1992. The role of chemical mediators peleased by the endothelium in the control of the cardiovascular system. Int. J. Tissue React., 14: 55-64.
46. Williams, D.J. and M. de Swiet, 1997. The pathophysiology of pre-eclampsia. Intensive Care Med., 23: 620-629.